DENTSPLY SIRONA Inc. (NASDAQ:XRAY) received a $63.00 price target from equities research analysts at Robert W. Baird in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the medical instruments supplier’s stock. Robert W. Baird’s price objective suggests a potential upside of 1.88% from the company’s previous close.
A number of other equities research analysts have also recently commented on XRAY. HC Wainwright restated a “buy” rating and set a $68.00 target price (down previously from $74.00) on shares of DENTSPLY SIRONA in a research note on Monday, August 14th. Stifel Nicolaus restated a “buy” rating on shares of DENTSPLY SIRONA in a research note on Thursday. UBS AG restated a “neutral” rating and set a $59.00 target price (down previously from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 12th. Finally, TheStreet cut shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research note on Wednesday, August 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $65.60.
DENTSPLY SIRONA (NASDAQ:XRAY) opened at 61.84 on Thursday. The stock’s market cap is $14.19 billion. The company’s 50-day moving average is $58.51 and its 200 day moving average is $61.00. DENTSPLY SIRONA has a 52 week low of $52.54 and a 52 week high of $65.68.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, hitting analysts’ consensus estimates of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The company had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. During the same quarter last year, the business earned $0.76 EPS. The firm’s revenue was down 2.9% compared to the same quarter last year. On average, analysts expect that DENTSPLY SIRONA will post $2.68 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This piece of content was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://stocknewstimes.com/2017/10/21/dentsply-sirona-inc-xray-pt-set-at-63-00-by-robert-w-baird.html.
A number of institutional investors and hedge funds have recently made changes to their positions in XRAY. BlackRock Inc. grew its holdings in DENTSPLY SIRONA by 3,103.7% during the 1st quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after buying an additional 13,457,730 shares in the last quarter. Clearbridge Investments LLC grew its holdings in DENTSPLY SIRONA by 34.6% during the 1st quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock valued at $328,313,000 after buying an additional 1,353,040 shares in the last quarter. Principal Financial Group Inc. grew its holdings in DENTSPLY SIRONA by 22.3% during the 2nd quarter. Principal Financial Group Inc. now owns 6,474,432 shares of the medical instruments supplier’s stock valued at $419,802,000 after buying an additional 1,181,547 shares in the last quarter. Point72 Asset Management L.P. purchased a new stake in DENTSPLY SIRONA during the 1st quarter valued at approximately $64,184,000. Finally, Renaissance Technologies LLC grew its holdings in DENTSPLY SIRONA by 246.0% during the 1st quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock valued at $65,222,000 after buying an additional 742,700 shares in the last quarter. 93.87% of the stock is owned by institutional investors and hedge funds.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.